These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 25223811)

  • 1. Impact of clinical and therapeutic factors on incident cardiovascular and cerebrovascular events in a population-based cohort of HIV-infected and non-HIV-infected adults.
    Tripathi A; Liese AD; Winniford MD; Jerrell JM; Albrecht H; Rizvi AA; Zhang J; Duffus WA
    Clin Cardiol; 2014 Sep; 37(9):517-22. PubMed ID: 25223811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of clinical and therapeutic factors with incident dyslipidemia in a cohort of human immunodeficiency virus-infected and non-infected adults: 1994-2011.
    Tripathi A; Jerrell JM; Liese AD; Zhang J; Rizvi AA; Albrecht H; Duffus WA
    Metab Syndr Relat Disord; 2013 Dec; 11(6):417-26. PubMed ID: 23909647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of diabetes mellitus in a population-based cohort of HIV-infected and non-HIV-infected persons: the impact of clinical and therapeutic factors over time.
    Tripathi A; Liese AD; Jerrell JM; Zhang J; Rizvi AA; Albrecht H; Duffus WA
    Diabet Med; 2014 Oct; 31(10):1185-93. PubMed ID: 24673640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe infection increases cardiovascular risk among HIV-infected individuals.
    Mesquita EC; Coelho LE; Amancio RT; Veloso V; Grinsztejn B; Luz P; Bozza FA
    BMC Infect Dis; 2019 Apr; 19(1):319. PubMed ID: 30975092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of primary hypertension in a population-based cohort of HIV-infected compared with non-HIV-infected persons and the effect of combined antiretroviral therapy.
    Tripathi A; Jerrell JM; Skelton TN; Nickels MA; Duffus WA
    J Am Soc Hypertens; 2015 May; 9(5):351-7. PubMed ID: 25766497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Traditional and HIV-specific risk factors for cardiovascular morbidity and mortality among HIV-infected adults in Brazil: a retrospective cohort study.
    Diaz CM; Segura ER; Luz PM; Clark JL; Ribeiro SR; De Boni R; Eksterman L; Moreira R; Currier JS; Veloso VG; Grinsztejn B; Lake JE
    BMC Infect Dis; 2016 Aug; 16():376. PubMed ID: 27503230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Pill Burden on Adherence, Risk of Hospitalization, and Viral Suppression in Patients with HIV Infection and AIDS Receiving Antiretroviral Therapy.
    Scott Sutton S; Magagnoli J; Hardin JW
    Pharmacotherapy; 2016 Apr; 36(4):385-401. PubMed ID: 26923931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV infection and cardiovascular disease in women.
    Womack JA; Chang CC; So-Armah KA; Alcorn C; Baker JV; Brown ST; Budoff M; Butt AA; Gibert C; Goetz MB; Gottdiener J; Gottlieb S; Justice AC; Leaf D; McGinnis K; Rimland D; Rodriguez-Barradas MC; Sico J; Skanderson M; Tindle H; Tracy RP; Warner A; Freiberg MS
    J Am Heart Assoc; 2014 Oct; 3(5):e001035. PubMed ID: 25324353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular and Cerebrovascular Events Are Associated With Nontraumatic Osteonecrosis of the Femoral Head.
    Sung PH; Yang YH; Chiang HJ; Chiang JY; Chen CJ; Yip HK; Lee MS
    Clin Orthop Relat Res; 2018 Apr; 476(4):865-874. PubMed ID: 29480889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Age-related Comorbidities on Five-year Overall Mortality among Elderly HIV-Infected Patients in the Late HAART Era--Role of Chronic Renal Disease.
    Hentzien M; Dramé M; Allavena C; Jacomet C; Valantin MA; Cabié A; Cuzin L; Rey D; Pugliese P; Bani-Sadr F;
    J Nutr Health Aging; 2016 Apr; 20(4):408-14. PubMed ID: 26999241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of Cardiometabolic Diseases in People With and Without Human Immunodeficiency Virus in the United Kingdom: A Population-Based Matched Cohort Study.
    Gooden TE; Gardner M; Wang J; Jolly K; Lane DA; Benjamin LA; Mwandumba HC; Kandoole V; Lwanga IB; Taylor S; Manaseki-Holland S; Lip GYH; Nirantharakumar K; Thomas GN
    J Infect Dis; 2022 Apr; 225(8):1348-1356. PubMed ID: 34417792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment.
    Capeau J; Bouteloup V; Katlama C; Bastard JP; Guiyedi V; Salmon-Ceron D; Protopopescu C; Leport C; Raffi F; Chêne G;
    AIDS; 2012 Jan; 26(3):303-14. PubMed ID: 22089377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared With the General Population.
    Drozd DR; Kitahata MM; Althoff KN; Zhang J; Gange SJ; Napravnik S; Burkholder GA; Mathews WC; Silverberg MJ; Sterling TR; Heckbert SR; Budoff MJ; Van Rompaey S; Delaney JAC; Wong C; Tong W; Palella FJ; Elion RA; Martin JN; Brooks JT; Jacobson LP; Eron JJ; Justice AC; Freiberg MS; Klein DB; Post WS; Saag MS; Moore RD; Crane HM
    J Acquir Immune Defic Syndr; 2017 Aug; 75(5):568-576. PubMed ID: 28520615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular disease among people living with HIV in Brazil.
    Boettiger DC; Escuder MM; Law MG; Veloso V; Souza RA; Ikeda MLR; de Alencastro PR; Tupinambás U; Brites C; Grinsztejn B; Ggomes JO; Ribeiro S; McGowan CC; Jayathilake K; Castilho JL; Grangeiro A
    Trop Med Int Health; 2020 Jul; 25(7):886-896. PubMed ID: 32306480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex differences in overall and cause-specific mortality among HIV-infected adults on antiretroviral therapy in Europe, Canada and the US.
    Antiretroviral Therapy Cohort Collaboration (ART-CC)
    Antivir Ther; 2015; 20(1):21-8. PubMed ID: 24675571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the reactivation of herpesviruses and inflammation as cardiovascular and cerebrovascular risk factors in antiretroviral therapy initiators in an African HIV-infected population (RHICCA): a protocol for a longitudinal cohort study.
    Peterson I; Ntsui N; Jambo K; Kelly C; Huwa J; Afran L; Tatuene JK; Pett S; Henrion MYR; Van Oosterhout J; Heyderman RS; Mwandumba H; Benjamin LA;
    BMJ Open; 2019 Sep; 9(9):e025576. PubMed ID: 31515413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of combination antiretroviral therapies on the risk of myocardial infarction among HIV patients.
    Brouwer ES; Napravnik S; Eron JJ; Stalzer B; Floris-Moore M; Simpson RJ; Stürmer T
    Epidemiology; 2014 May; 25(3):406-17. PubMed ID: 24713880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral therapy regimen modification rates and associated factors in a cohort of HIV/AIDS patients in Asmara, Eritrea: a 16-year retrospective analysis.
    Mengistu ST; Yohannes A; Issaias H; Mesfn M; Zerufael S; Dirar A; Teklemariam HM; Ghebremeskel GG; Achila OO; Basha S
    Sci Rep; 2023 Mar; 13(1):4183. PubMed ID: 36918596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4/CD8 Ratio and CD4 Nadir Predict Mortality Following Noncommunicable Disease Diagnosis in Adults Living with HIV.
    Castilho JL; Turner M; Shepherd BE; Koethe JR; Furukawa SS; Bofill CE; Raffanti S; Sterling TR
    AIDS Res Hum Retroviruses; 2019 Oct; 35(10):960-967. PubMed ID: 31407605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection.
    Bozzette SA; Ake CF; Tam HK; Chang SW; Louis TA
    N Engl J Med; 2003 Feb; 348(8):702-10. PubMed ID: 12594314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.